India-Singapore Business Submit – Innovating for Mass Market

Smiley face

Within the kidney space, more than 100 million people in India have Chronic Kidney Disease (CKD) and while about 1 million of them have end-stage kidney disease, only 100,000 get treatment.

Mr Mandar Gori of AWAK participated in panel discussion at the conference with other esteemed industry leaders on how to facilitate innovation between the India and Singapore biotechnology industries to help overcome challenges and create opportunities for health revolution.

© 2020 AWAK Technologies. All Rights Reserved.